RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Taisho Pharmaceutical Holdings Co Stock

Taisho Pharmaceutical Holdings Co Net Income 2024

Taisho Pharmaceutical Holdings Co Net Income

11.97 B JPY

Ticker

4581.T

ISIN

JP3442850008

WKN

A1JKG0

In 2024, Taisho Pharmaceutical Holdings Co's profit amounted to 11.97 B JPY, a -37% increase from the 19 B JPY profit recorded in the previous year.

The Taisho Pharmaceutical Holdings Co Net Income history

YEARNET INCOME (undefined JPY)
2027e14.07
2026e14.44
2025e18.28
2024e11.97
202319
202213.12
202113.32
202020.17
201948.59
201831.68
201728.78
201622.47
201524.53
201432.69
201326.32
201224.36

Taisho Pharmaceutical Holdings Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Taisho Pharmaceutical Holdings Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Taisho Pharmaceutical Holdings Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Taisho Pharmaceutical Holdings Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Taisho Pharmaceutical Holdings Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Taisho Pharmaceutical Holdings Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Taisho Pharmaceutical Holdings Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Taisho Pharmaceutical Holdings Co’s growth potential.

Taisho Pharmaceutical Holdings Co Revenue, EBIT and net profit per share

DateTaisho Pharmaceutical Holdings Co RevenueTaisho Pharmaceutical Holdings Co EBITTaisho Pharmaceutical Holdings Co Net Income
2027e297.64 B undefined0 undefined14.07 B undefined
2026e315.42 B undefined0 undefined14.44 B undefined
2025e329.51 B undefined23.43 T undefined18.28 B undefined
2024e324.97 B undefined23.03 T undefined11.97 B undefined
2023301.38 B undefined23.02 B undefined19 B undefined
2022268.2 B undefined10.74 B undefined13.12 B undefined
2021281.98 B undefined19.97 B undefined13.32 B undefined
2020288.53 B undefined21.14 B undefined20.17 B undefined
2019261.55 B undefined31.21 B undefined48.59 B undefined
2018280.09 B undefined36.98 B undefined31.68 B undefined
2017279.77 B undefined31.97 B undefined28.78 B undefined
2016290.14 B undefined28.88 B undefined22.47 B undefined
2015290.5 B undefined31.97 B undefined24.53 B undefined
2014295.96 B undefined41.68 B undefined32.69 B undefined
2013285.17 B undefined35.34 B undefined26.32 B undefined
2012271.23 B undefined38.41 B undefined24.36 B undefined

Taisho Pharmaceutical Holdings Co stock margins

The Taisho Pharmaceutical Holdings Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Taisho Pharmaceutical Holdings Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Taisho Pharmaceutical Holdings Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Taisho Pharmaceutical Holdings Co's sales revenue. A higher gross margin percentage indicates that the Taisho Pharmaceutical Holdings Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Taisho Pharmaceutical Holdings Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Taisho Pharmaceutical Holdings Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Taisho Pharmaceutical Holdings Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Taisho Pharmaceutical Holdings Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Taisho Pharmaceutical Holdings Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Taisho Pharmaceutical Holdings Co Margin History

Taisho Pharmaceutical Holdings Co Gross marginTaisho Pharmaceutical Holdings Co Profit marginTaisho Pharmaceutical Holdings Co EBIT marginTaisho Pharmaceutical Holdings Co Profit margin
2027e59.01 %0 %4.73 %
2026e59.01 %0 %4.58 %
2025e59.01 %7,111.1 %5.55 %
2024e59.01 %7,086.24 %3.68 %
202359.01 %7.64 %6.3 %
202261.09 %4.01 %4.89 %
202162.39 %7.08 %4.72 %
202062.43 %7.33 %6.99 %
201965.13 %11.93 %18.58 %
201865.31 %13.2 %11.31 %
201763.71 %11.43 %10.29 %
201661 %9.95 %7.75 %
201561.36 %11.01 %8.44 %
201462.4 %14.08 %11.05 %
201361.81 %12.39 %9.23 %
201263.5 %14.16 %8.98 %

Taisho Pharmaceutical Holdings Co Aktienanalyse

What does Taisho Pharmaceutical Holdings Co do?

Taisho Pharmaceutical Holdings Co Ltd is a leading Japanese pharmaceutical company specializing in the development and distribution of drugs and health products. The company is headquartered in Tokyo and has been active since its establishment in 1912. Taisho Pharmaceutical Holdings Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Taisho Pharmaceutical Holdings Co's Profit Margins

The profit margins of Taisho Pharmaceutical Holdings Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Taisho Pharmaceutical Holdings Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Taisho Pharmaceutical Holdings Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Taisho Pharmaceutical Holdings Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Taisho Pharmaceutical Holdings Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Taisho Pharmaceutical Holdings Co stock

How much profit has Taisho Pharmaceutical Holdings Co made this year?

Taisho Pharmaceutical Holdings Co has made 11.97 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by -37% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Taisho Pharmaceutical Holdings Co publish its earnings?

Taisho Pharmaceutical Holdings Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Taisho Pharmaceutical Holdings Co?

The profits of Taisho Pharmaceutical Holdings Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Taisho Pharmaceutical Holdings Co?

You can learn more about the earnings of Taisho Pharmaceutical Holdings Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Taisho Pharmaceutical Holdings Co pay?

Over the past 12 months, Taisho Pharmaceutical Holdings Co paid a dividend of 100 JPY . This corresponds to a dividend yield of about 1.17 %. For the coming 12 months, Taisho Pharmaceutical Holdings Co is expected to pay a dividend of 100.72 JPY.

What is the dividend yield of Taisho Pharmaceutical Holdings Co?

The current dividend yield of Taisho Pharmaceutical Holdings Co is 1.17 %.

When does Taisho Pharmaceutical Holdings Co pay dividends?

Taisho Pharmaceutical Holdings Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Taisho Pharmaceutical Holdings Co?

Taisho Pharmaceutical Holdings Co paid dividends every year for the past 16 years.

What is the dividend of Taisho Pharmaceutical Holdings Co?

For the upcoming 12 months, dividends amounting to 100.72 JPY are expected. This corresponds to a dividend yield of 1.17 %.

In which sector is Taisho Pharmaceutical Holdings Co located?

Taisho Pharmaceutical Holdings Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Taisho Pharmaceutical Holdings Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Taisho Pharmaceutical Holdings Co from 6/1/2024 amounting to 50 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Taisho Pharmaceutical Holdings Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Taisho Pharmaceutical Holdings Co in the year 2023?

In the year 2023, Taisho Pharmaceutical Holdings Co distributed 100 JPY as dividends.

In which currency does Taisho Pharmaceutical Holdings Co pay out the dividend?

The dividends of Taisho Pharmaceutical Holdings Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Taisho Pharmaceutical Holdings Co

Our stock analysis for Taisho Pharmaceutical Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Taisho Pharmaceutical Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.